JPRN-jRCT2080220534未知3 期
A Phase III Trial to Test the Efficacy of ZD4054, an Endothelin A Receptor Antagonist, Versus Placebo in Patients With Hormone Resistant Prostate Cancer (HRPC) and Bone Metastasis Who Are Pain Free and Mildly Symptomatic.
适应症
试验速览
- 阶段
- 3 期
- 发起方
- AstraZeneca
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- Male
入选标准
- •Ages Eligible for Study: 18 Years and older (Japan: 20 Years and older)
- •Genders Eligible for Study: Male
- •Accepts Healthy Volunteers: No
- •Inclusion Criteria:
- •-Patients who answer TRUE to the following criteria may be eligible to participate in this trial.
- •1. Confirmed diagnosis of prostate cancer (adenocarcinoma of the prostate) that has spread to the bone (bone metastases)
- •2. Increasing Prostate Specific Antigen (PSA) over a one month period
- •3. No pain, or mild pain from prostate cancer
- •4. Currently receiving treatment with surgical or medical castration
排除标准
- •-Patients who answer TRUE to the following may NOT eligible to participate in this trial.
- •1. Currently using opiates based pain killers
- •2. Previous treatment with chemotherapy (paclitaxel, docetaxel, and mitoxantrone)
- •3. Suffering from heart failure or had a myocardial infarction within last 6 months
- •4. A history of epilepsy or seizures
研究者
相似试验
未知
3 期
ZO-Y49 PhaseIII clinical trialGynecologic DiseaseJPRN-jRCT2080220729ZERIA Pharmaceutical Co.,Ltd.
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-C000000300Zeria Pharmaceutical Co.,LTD60
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with Crohn's disease in active phasePatients with Crohn's disease in active phaseJPRN-jRCT2080220189Zeria Pharmaceutical Co., Ltd.
已完成
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-maintaining effect in patients with ulcerative colitis in remission phasePatients with ulcerative colitis in remission phase.JPRN-C000000289Zeria Pharmaceutical Co.,LTD.120
未知
3 期
Z-206 Phase III Clinical Trial - Investigation on the remission-inducing effect in patients with ulcerative colitis in active phasePatients with ulcerative colitis in active phaseJPRN-jRCT2080220176ZERIA Pharmaceutical Co.,Ltd.